Searched over 200M research papers
10 papers analyzed
Some studies suggest aspirin can prevent certain cancers, particularly colorectal, oesophageal, and gastric cancers, while other studies indicate it does not significantly reduce cancer-related mortality or incidence and may increase bleeding risks.
18 papers analyzed
20 papers analyzed
Aspirin, a widely used medication for pain relief and cardiovascular disease prevention, has been investigated for its potential role in cancer prevention. This synthesis examines the evidence from multiple research studies to determine whether aspirin can effectively prevent cancer.
Colorectal Cancer Prevention:
Other Cancer Types:
General Cancer Prevention:
Safety and Risks:
Aspirin shows promise in preventing colorectal cancer, particularly in individuals aged 50-70 years with a higher risk of cardiovascular disease. There is also potential for reducing the risk of other cancers, but the evidence is less conclusive. The primary concern with aspirin use is the increased risk of gastrointestinal bleeding, which necessitates careful consideration of individual risk factors. Overall, while aspirin may offer benefits in cancer prevention, its use should be tailored to individual health profiles and risk assessments.
Most relevant research papers on this topic